| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |